warnings
If symptoms worsen or persist for more than 7 days, consult a physician.
Gelsemium Sempervirens 30X
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Gelsemium Sempervirens 30X
- Generic name
- GELSEMIUM SEMPERVIRENS
- Manufacturer
- Laboratoire Schmidt-Nagel Inc.
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 3362f80f-7905-3d5e-e063-6294a90a0c45
- SPL ID
- 35936d97-51c3-c128-e063-6394a90af250
- Version
- 2
- Effective date
- 2025-05-20
- Source export date
- 2026-11-06
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/b0d9ca61dc485ebaf55e14a76d7d677668e40ef1e1978cdbcc4d73d58eba0b99/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 07:47:18
| Harmonized routes |
|---|
| ORAL, SUBLINGUAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Gelsemium Sempervirens 30X | openfda.brand_name | |
| generic name | GELSEMIUM SEMPERVIRENS | openfda.generic_name | |
| manufacturer name | Laboratoire Schmidt-Nagel Inc. | openfda.manufacturer_name | |
| ndc | package | 73296-013-01 | openfda.package_ndc |
| ndc | product | 73296-013 | openfda.product_ndc |
| ndc11 | package | 73296001301 | derived:openfda.package_ndc |
| spl id | 35936d97-51c3-c128-e063-6394a90af250 | id | |
| spl set id | 3362f80f-7905-3d5e-e063-6294a90a0c45 | set_id | |
| unii | 639KR60Q1Q | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.